Home
>
National Drug Code (NDC)
>
DOBUTamine
DOBUTamine - 0409-2025-20 - (DOBUTAMINE HYDROCHLORIDE)
Drug Information of DOBUTamine
| Product NDC: | 0409-2025 |
| Proprietary Name: | DOBUTamine |
| Non Proprietary Name: | DOBUTAMINE HYDROCHLORIDE |
| Active Ingredient(s): | 12.5 mg/mL & nbsp; DOBUTAMINE HYDROCHLORIDE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of DOBUTamine
| Product NDC: | 0409-2025 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074292 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19950216 |
Package Information of DOBUTamine
| Package NDC: | 0409-2025-20 |
| Package Description: | 10 BOX in 1 CASE (0409-2025-20) > 10 VIAL, SINGLE-DOSE in 1 BOX > 20 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of DOBUTamine
| NDC Code | 0409-2025-20 |
| Proprietary Name | DOBUTamine |
| Package Description | 10 BOX in 1 CASE (0409-2025-20) > 10 VIAL, SINGLE-DOSE in 1 BOX > 20 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0409-2025 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DOBUTAMINE HYDROCHLORIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19950216 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | DOBUTAMINE HYDROCHLORIDE |
| Strength Number | 12.5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] |
